United Kingdom· GB-APID-30026311000001100
Almotriptan 12.5mg tablets
A almotriptan product containing almotriptan, registered in United Kingdom by DE Pharmaceuticals. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Almotriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC05 (almotriptan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Almotriptan · ATC N02CC05
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of almotriptan costs, country by country.
Normalised to the WHO defined daily dose (12.5 mg), the median price runs from $1.25 in France to $6.02 in Switzerland — a ×4.8 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Almotriptan · price per daily dose (12.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.02
- ES Spain$5.56
- IT Italy$3.29
- FR France$1.25
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Almotriptan
- Manufacturer
- DE Pharmaceuticals
- Country
- United Kingdom (GB)
- ATC code
- N02CC05
- ATC class
- Almotriptan
- Defined daily dose
- 12.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for almotriptan.
Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Almotriptan · interactions on record
81 records
- 13 severe
- 29 moderate
- 38 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Almotriptan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaALMOTRIPTANSANIS HEALTH INC
- SpainALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlmirall S.A.
- ItalyALMOGRANDIFARMED S.L.U.
- FranceALMOGRAN 12,5 mg, comprimé pelliculéALMIRALL
- SwedenAlmogran 12,5 mg Filmdragerad tablettAlmirall S.A.
- FinlandAlmogranOrifarm Oy
- PolandAlmozenDelfarma Sp. z o.o.
- NetherlandsAlmogran 12,5 mg filmomhulde tablettenOriginalis B.V.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Almogran
- Germany · Almogran, Almotriptan Bei Migräne Heumann
- Spain · Almogran, Almotriptán Cinfa
- Finland · Almogran
- France · Almogran, Almotriptan Biogaran
- Greece · Almogran
- Ireland · Almogran
- Italy · Almogran, Almotrex
- Luxembourg · Almogran
- Netherlands · Almogran
- Norway · Almogran, Almotriptan Orifarm
- Poland · Nomigren, Trymigan
- Portugal · Almogran, Almotriptano Galenicum
- Sweden · Almogran, Almotriptan Orifarm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e666f548-0672-491d-bcb0-a70c33974db5 GET /v1/drugs/e666f548-0672-491d-bcb0-a70c33974db5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "30026311000001100",
"desc": "Almotriptan 12.5mg tablets (DE Pharmaceuticals)",
"form": "Oral tablet",
"vpid": "39731611000001103",
"source": "dmd",
"vtm_id": "774487003",
"strength": "12.5 mg",
"substance": "Almotriptan",
"ingredient": "Almotriptan hydrogen malate",
"supplier_code": "2268901000001109"
}See everything about almotriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.